Topic: research

Approximately one in seven couples face difficulties conceiving a child naturally. Half of these cases are due to male infertility – either caused by the complete absence or low number of mature sperm.

On 3 May at 12:15, Ahto Salumets will defend his thesis "Bioinformatics analysis of various aspects in immunology“.

Publications of the RNA Biology Research Group

1. jaanuaril algas Euroopa Komisjoni projekt POINT, mille raames uuritakse Covid-19 pikaajalist tervisemõju.

Biokeemia osakonna publikatsioonid ja patendid

Imagining a future entirely different from today can be the most effective risk adaptation strategy. At the Scientific Advisory Board’s conference “Viirustega tulevikku” (“To the future with viruses”), a panel of top Estonian scientists and officials discussed what resources and decisions future pandemics require and what trends influence how Estonian society will cope with pandemics in the upcoming decades. The panel discussion “Pandemics in a future society” was moderated by Triin Vihalemm, Professor of Communication Studies at the University of Tartu.

The general assembly of the Estonian Academy of Science selected Pärt Peterson, Professor of Molecular Immunology at the University of Tartu as a member of the academy in the field of biomedicine. 

Last week, the US Food and Drug Administration (FDA) approved the world's first vaccine against the chikungunya virus – Ixchiq. The vaccine candidate has been designed and manufactured at the University of Tartu. The human clinical trials were conducted by the biotechnology company Valneva Austria GmbH.